{"id":784691,"date":"2023-09-18T16:19:45","date_gmt":"2023-09-18T20:19:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/"},"modified":"2023-09-18T16:19:45","modified_gmt":"2023-09-18T20:19:45","slug":"tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/","title":{"rendered":"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MALVERN, Pa., Sept.  18, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rzsYq2pJRJQiPv1J8RjCHV7QID2d03j8PJpL3OzbMeJKiNnomxdjnF79xvMP3cwram6NhfEX7P9U4nz1RQkb9Urg-QP-KUaU7cBekbZgzjCIl2LA-OmRL_XNzKkQpl-FEvcLDgxrLxWBFJSNABC8PHa1KHdpq4lB1zO5PJ6bNnQo7FWRt5-6YBSyUZ0zM9KWqCQXpOYvU5FukZlCHBHu1YRQ5c9nxbAfkqbBuyL5WKk=\" rel=\"nofollow noopener\" target=\"_blank\"><u>TELA Bio, Inc<\/u><\/a>. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient&#8217;s own anatomy, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase.<\/p>\n<p align=\"justify\">TELA\u2019s management is scheduled to present at the Gilmartin Group Emerging Growth Company Showcase at 9:30 am ET on September 21<sup>st<\/sup>, 2023. Interested parties can access the live and archived webcast at ir.telabio.com.<\/p>\n<p align=\"justify\">\n        <strong>About TELA Bio, Inc.<\/strong><br \/>\n        <br \/>TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient&#8217;s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient&#8217;s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Greg Chodaczek<br \/>347-620-7010<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tWcRk8P5ftZjq3Wy1RvSMNoIitbEE4nbTMZdfJKlWV8tpSud8zUkejH1VGGAbZSAvPUBr-QfIRqGognAmXvcmA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>ir@telabio.com<\/u><\/a>\u00a0\u00a0\u00a0\u00a0<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODZlNjhjM2MtZWUxZS00OThiLThiNjMtNzk3NmExMzEyZDk5LTExOTE3MDg=\/tiny\/Tela-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient&#8217;s own anatomy, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase. TELA\u2019s management is scheduled to present at the Gilmartin Group Emerging Growth Company Showcase at 9:30 am ET on September 21st, 2023. Interested parties can access the live and archived webcast at ir.telabio.com. About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-784691","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient&#8217;s own anatomy, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase. TELA\u2019s management is scheduled to present at the Gilmartin Group Emerging Growth Company Showcase at 9:30 am ET on September 21st, 2023. Interested parties can access the live and archived webcast at ir.telabio.com. About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the &hellip; Continue reading &quot;TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-18T20:19:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase\",\"datePublished\":\"2023-09-18T20:19:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/\"},\"wordCount\":179,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/\",\"name\":\"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=\",\"datePublished\":\"2023-09-18T20:19:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/","og_locale":"en_US","og_type":"article","og_title":"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase - Market Newsdesk","og_description":"MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient&#8217;s own anatomy, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase. TELA\u2019s management is scheduled to present at the Gilmartin Group Emerging Growth Company Showcase at 9:30 am ET on September 21st, 2023. Interested parties can access the live and archived webcast at ir.telabio.com. About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the &hellip; Continue reading \"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-18T20:19:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase","datePublished":"2023-09-18T20:19:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/"},"wordCount":179,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/","name":"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=","datePublished":"2023-09-18T20:19:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDE0OSM1ODIwMDQ2IzIxODAxMzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-participate-in-the-gilmartin-group-emerging-growth-company-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=784691"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784691\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=784691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=784691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=784691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}